Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 328 | 515 | 700 | 907 | 1,831 |
| TOTAL | $477 | $653 | $708 | $938 | $1,952 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 7 | 7 | 7 | 7 | 7 |
| TOTAL | $5,129 | $5,129 | $5,129 | $5,129 | $5,129 |
| Total Assets | $5,606 | $5,782 | $5,837 | $6,067 | $7,081 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 68 | 122 | 134 | 349 | 575 |
| Accrued Expenses | 539 | 621 | 338 | 314 | 308 |
| TOTAL | $607 | $743 | $471 | $662 | $883 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $607 | $743 | $471 | $662 | $883 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 930 | 930 | 789 | 789 | 756 |
| Common Shares | 126 | 119 | 113 | 108 | 108 |
| Retained earnings | -101,165 | -100,031 | -98,892 | -98,216 | -97,180 |
| Other shareholders' equity | -21 | -14 | -9 | -12 | -6 |
| TOTAL | $5,000 | $5,040 | $5,366 | $5,404 | $6,198 |
| Total Liabilities And Equity | $5,606 | $5,782 | $5,837 | $6,067 | $7,081 |